首页> 外文会议>Society for Biomaterials annual meeting and exposition >Biodistribution of Cancer Stem Cells Targeting Nanoparticle Image Contrast Agents and it's Implications in Early Diagnosis
【24h】

Biodistribution of Cancer Stem Cells Targeting Nanoparticle Image Contrast Agents and it's Implications in Early Diagnosis

机译:靶向纳米颗粒图像造影剂的癌症干细胞生物分布,并对早期诊断产生影响

获取原文

摘要

Using the modular approach of nanoparticle synthesis we had previously published, we successfully created CD133 targeting, CY5 fluorescent, Au@SiO_2 core-shell NPs with >12h of persistence in the blood pool of mice. The nanoprobes successfully targeted CD133(+) ovarian cancer cells in vitro and more importantly, the in vivo tumor location and margin could be determined noninvasively by CT and was correlated with in vivo fluorescence imaging. We were also able to quantify the mass of nanoparticles per unit mass of tumor tissue therefore allowing us to estimate the targeting efficiency of our probes. The data obtained from this study can be used to further optimize targeting strategies to not only image disease sites but also deliver therapeutic molecules for the broad detection and treatment of multiple diseases.
机译:使用纳米粒子合成的模块化方法我们先前已发表,我们成功地创建了CD133靶向,Cy5荧光,Au @ SiO_2核心壳NPS,在小鼠的血液池中持续存在。纳米素在体外成功地靶向CD133(+)卵巢癌细胞,更重要的是,可以通过CT非血管肿瘤位置和裕度来确定,并与体内荧光成像相关。我们还能够量化每单位肿瘤组织的纳米颗粒的质量,因此允许我们估计探针的靶向效率。从该研究中获得的数据可用于进一步优化靶向策略,不仅是图像疾病部位,而且还提供治疗分子,用于广泛的检测和治疗多种疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号